Lexicon Pharma (LXRX) Announces Sale of XERMELO for $159 Million

Go back to Lexicon Pharma (LXRX) Announces Sale of XERMELO for $159 Million
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) Delayed: 2.05 --0 (-0%)
Previous Close $2.05    52 Week High $19.62 
Open $2.05    52 Week Low $7.65 
Day High $2.05    P/E N/A 
Day Low $2.05    EPS $-0.22 
Volume 10